1. Home
  2. PD vs RLAY Comparison

PD vs RLAY Comparison

Compare PD & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PagerDuty Inc.

PD

PagerDuty Inc.

HOLD

Current Price

$13.11

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$8.39

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PD
RLAY
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
PD
RLAY
Price
$13.11
$8.39
Analyst Decision
Buy
Strong Buy
Analyst Count
10
7
Target Price
$17.70
$16.00
AVG Volume (30 Days)
1.8M
2.2M
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.63
N/A
Revenue
$489,207,000.00
$8,355,000.00
Revenue This Year
$8.16
$20.47
Revenue Next Year
$3.88
N/A
P/E Ratio
$8.19
N/A
Revenue Growth
7.01
N/A
52 Week Low
$11.13
$1.78
52 Week High
$20.00
$9.04

Technical Indicators

Market Signals
Indicator
PD
RLAY
Relative Strength Index (RSI) 47.10 60.20
Support Level $12.69 $8.25
Resistance Level $13.56 $8.76
Average True Range (ATR) 0.33 0.45
MACD 0.16 -0.03
Stochastic Oscillator 58.06 61.41

Price Performance

Historical Comparison
PD
RLAY

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: